Pharmacologic management of cognitive impairment induced by cancer therapy
… treated 24 adult patients with primary brain tumour, who were randomised to either open-label
modafinil (200 mg daily) or open-label methylphenidate (18 mg daily or 10 mg twice daily…
modafinil (200 mg daily) or open-label methylphenidate (18 mg daily or 10 mg twice daily…
Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer
… It is estimated to cost more than 480 billion euros each year throughout the world (Sources:
OMS, EBC (European Brain Council)). Currently, no pharmacological treatment is available …
OMS, EBC (European Brain Council)). Currently, no pharmacological treatment is available …
Glioblastoma and other primary brain malignancies in adults: a review
LR Schaff, IK Mellinghoff - Jama, 2023 - jamanetwork.com
… Importance Malignant primary brain tumors cause more than 15 000 deaths per year in the
… incidence of primary malignant brain tumors is approximately 7 per 100 000 individuals and …
… incidence of primary malignant brain tumors is approximately 7 per 100 000 individuals and …
Glioblastoma: clinical presentation, diagnosis, and management
… common primary brain cancer in adults.… Depression can affect 1 in 5 patients with glioma.No
RCTs to date have investigated the efficacy of pharmacological treatments for depression …
RCTs to date have investigated the efficacy of pharmacological treatments for depression …
The effects of brain tumours upon medical decision-making capacity
… brain tumour patients’ capacity to consent to research. Due to the relatively poor outcomes of
interventions available to brain tumour patients, … and consent forms, patients may be ‘at-risk’ …
interventions available to brain tumour patients, … and consent forms, patients may be ‘at-risk’ …
Symptom Clusters in Patients With Brain Tumors Undergoing Proton Beam Therapy.
U Langegård, B Johansson… - Oncology Nursing …, 2019 - search.ebscohost.com
… beam therapy in patients with primary brain tumors and … 187 adult patients with primary brain
tumors during their treatment … Medical data regarding the participants’ tumor and treatment …
tumors during their treatment … Medical data regarding the participants’ tumor and treatment …
Interventions for the management of fatigue in adults with a primary brain tumour
J Day, S Yust-Katz, D Cachia, J Wefel… - Cochrane Database …, 2022 - cochranelibrary.com
… in the management of people with primary brain tumour and … ‐medicine interventions, such
as talking therapy and exercise… We defined non‐pharmacological interventions and general …
as talking therapy and exercise… We defined non‐pharmacological interventions and general …
Pharmacological treatments for patients with treatment-resistant depression
VL Ruberto, MK Jha, JW Murrough - Pharmaceuticals, 2020 - mdpi.com
… Y as a treatment for mood and anxiety disorders, and on a patent pending for the use of
ezogabine and other KCNQ channel openers to treat depression and related conditions. The …
ezogabine and other KCNQ channel openers to treat depression and related conditions. The …
Executive dysfunction in neuro-oncology: Behavior Rating Inventory of Executive Function in adult primary brain tumor patients
… More specifically, we are interested in the specific index and subscale profile shown in
PBT patients, especially when compared to other medical populations and healthy controls, …
PBT patients, especially when compared to other medical populations and healthy controls, …
Long‐term issues and supportive care needs of adolescent and young adult childhood brain tumour survivors and their caregivers: a systematic review
… Long‐term issues following diagnosis and treatment of a childhood brain tumour often …
young adult (AYA) survivors of a brain tumour diagnosed in childhood and their caregivers. …
young adult (AYA) survivors of a brain tumour diagnosed in childhood and their caregivers. …